[1] |
BRINK A J. Epidemiology of carbapenem-resistant Gram-negative infections globally[J]. Curr Opin Infect Dis, 2019, 32(6):609-616.
DOI
PMID
|
[2] |
GANDRA S, BURNHAM C D. Carbapenem-resistant Enterobacterales in the USA[J]. Lancet Infect Dis, 2020, 20(6):637-639.
DOI
URL
|
[3] |
HANSEN G T. Continuous evolution:perspective on the epidemiology of carbapenemase resistance among Enterobacterales and other Gram-negative bacteria[J]. Infect Dis Ther, 2021, 10(1):75-92.
DOI
|
[4] |
PAVEENKITTIPORN W, LYMAN M, BIEDRON C, et al. Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand,2016-2018[J]. Antimicrob Resist Infect Control, 2021, 10(1):88.
DOI
|
[5] |
李鑫, 杨继勇. 碳青霉烯类耐药肠杆菌科细菌分布与流行特征研究进展[J]. 中华微生物学和免疫学杂志, 2019, 39(4):306-310.
|
[6] |
周海英, 曹原, 邓劲, 等. 氨曲南联合头孢他啶/阿维巴坦对产金属β-内酰胺酶肠杆菌目细菌的体外协同作用初探[J]. 中国抗生素杂志, 2021, 46(8):784-788.
|
[7] |
全国细菌耐药监测网. 全国细菌耐药监测网2014—2019年细菌耐药性监测报告[J]. 中国感染控制杂志, 2021, 20(1):15-30.
|
[8] |
National Center for Emerging and Zoonotic Infectious Diseases(U.S.),Division of Healthcare Quality Promotion. Facility guidance for control of carbapenem-resistant Enterobacteriaceae(CRE)November 2015 update[R/OL]. (2015-11-30)[2021-05-01]. https://www.cdc.gov/hai/pdfs/cre/CRE-guidance-508.pdf.
|
[9] |
曾云祥, 陈杨芳, 沈丽珍, 等. 携带blaIMP-4或blaKPC-2的产新德里金属β-内酰胺酶-1的肠杆菌科菌的基因型检测及其质粒转移传播机制的研究[J]. 中华传染病杂志, 2015, 33(9):542-549.
|
[10] |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. M100-Ed31,CLSI, 2021.
|
[11] |
Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing[S]. M100-S27,CLSI, 2017.
|
[12] |
LI Z, DING Z, YANG J, et al. Carbapenem-resistant Klebsiella pneumonia in southwest China:molecular characteristics and risk factors caused by KPC and NDM producers[J]. Infect Drug Resist, 2021, 14:3145-3158.
DOI
URL
|
[13] |
BALA R, SINGH V A, GUPTA N, et al. Prevalence,multidrug-resistance and risk factors for AmpC β-lactamases producing Escherichia coli from hospitalized patients[J]. J Infect Dev Ctries, 2020, 14(12):1466-1469.
DOI
URL
|
[14] |
YONG D, TOLEMAN M A, GISKE C G, et al. Characterization of a new metallo-β-lactamase gene,blaNDM-1,and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India[J]. Antimicrob Agents Chemother, 2009, 53(12):5046-5054.
DOI
URL
|
[15] |
QUEENAN A M, BUSH K. Carbapenemases:the versatile beta-lactamases[J]. Clin Microbiol Rev, 2007, 20(3):440-458.
DOI
URL
|
[16] |
LIM K T, YEO C C, MD YASIN R, et al. Characterization of multidrug-resistant and extended-spectrum β-lactamase-producing Klebsiella pneumoniae strains from Malaysian hospitals[J]. J Med Microbiol, 2009, 58(Pt 11):1463-1469.
DOI
URL
|
[17] |
YU Y, JI S, CHEN Y, et al. Resistance of strains producing extended-spectrum β-lactamases and genotype distribution in China[J]. J Infect, 2007, 54(1):53-57.
DOI
URL
|
[18] |
喻华, 徐雪松, 李敏, 等. 肠杆菌目细菌碳青霉烯酶的实验室检测和临床报告规范专家共识[J]. 中国感染与化疗杂志, 2020, 20(6):671-680.
DOI
|
[19] |
PORRECA A M, SULLIVAN K V, GALLAGHER J C. The epidemiology,evolution,and treatment of KPC-producing organisms[J]. Curr Infect Dis Rep, 2018, 20(6):13.
DOI
|
[20] |
TOMPKINS K, VAN DUIN D. Treatment for carbapenem-resistant Enterobacterales infections:recent advances and future directions[J]. Eur J Clin Microbiol Infect Dis, 2021, 40(10):2053-2068.
DOI
|